Skip to content

Clinical efficacy of ultrasound-guided erector spinae plane block in the perioperative analgesia of patients undergoing lumbar posterior endoscopic spinal decompression

Clinical efficacy of ultrasound-guided erector spinae plane block in the perioperative analgesia of patients undergoing lumbar posterior endoscopic spinal decompression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061908
Enrollment
Unknown
Registered
2022-07-10
Start date
2022-06-27
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

(Lumbar disc herniation and Lumbar spinal stenosis) , lumbar UBE (unilateral biportal endoscopic) surgery.

Interventions

Group 1:Erector spinae plane block (0.25% ropivacaine 20 ml, ESPB) at the level of the second transverse vertebral process above the operative segment + peripheral patient intravenous autocontrolled a
Group 2:No block, only peripheral patient intravenous autocontrolled analgesia (PCIA)

Sponsors

Binzhou Medical University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing posterior lumbar endoscopic spinal canal decompression or concurrent nucleus pulposus removal under elective general anesthesia. The surgical procedure is a lumbar UBE (unilateral biportal endoscopic) surgery. 2. Age: 18-65 years old; 3. ASA: I-III; 4. Informed consent of patients.

Exclusion criteria

Exclusion criteria: 1. ASA >= ?; 2. Allergy to local anesthetic (ropivacaine); 3. Infection at the puncture site; 4. History of lumbar open surgery; 5. Coagulation dysfunction or anticoagulant drugs are being used; 6. History of analgesic drug abuse; 7. Communication barriers; 8. The operation time is more than 3 hours.

Design outcomes

Primary

MeasureTime frame
Postoperative 24h and 48h fentanyl consumption;QoR-15 scores before surgery and at 24h and 48h after surgery;Intraoperative remifentanil consumption [µg/(Kg.min)];

Secondary

MeasureTime frame
Intraoperative myorelaxant dosage ;numeric rating scale (NRS) score;Time to first postoperative self-administered analgesia;Postoperative analgesic remediation rate;Postoperative opioid-related adverse reactions (nausea, vomiting, drowsiness, respiratory depression, etc.);Positive response rate of 10% increase in heart rate and or blood pressure in patients at four moments of skinning, fascial dilatation, clamping and biting of the periosteum and loosening of the retracted nerve roots;

Countries

China

Contacts

Public ContactDan Zhao

Binzhou Medical University Hospital

yanqingzd@126.com+86 157 6217 2592

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026